HaneenShalabiDO

PubMed

• 1 citations
  Intrathecal hydrocortisone for treatment of children and young adults with CAR T-cell immune-effector cell-associated neurotoxicity syndrome.
  Haneen Shalabi, Cynthia Harrison, Bonnie Yates, Katherine R Calvo, Daniel W Lee, Nirali N Shah> ;Pediatric Blood & Cancer. 2024 Jan 1
• 1 citations
  INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities.
  Emily M Hsieh, Haneen Shalabi, Rebecca Epperly, Pamela L Wolters, Joshua A Hill, Rebecca Gardner, Aimee C Talleur, Nirali N Shah, Jenna Rossoff, McNerney, K.> ;Transplantation and Cellular Therapy. 2024 Jan 1
• A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials.
  Sara K Silbert, Sanna Madan, Elizabeth M Holland, Seth M Steinberg, Lauren Little, Toni Foley, Monica Epstein, Angela Sarkisian, Daniel W Lee, Ekaterina Nikitina, Show...> ;Blood Advances. 2023 Sep 26
• 2 citations
  Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.
  Elizabeth M Holland, Bonnie Yates, Seth M Steinberg, Constance M Yuan, Hao-Wei Wang, Colleen Annesley, Haneen Shalabi, David Stroncek, Terry J Fry, Joerg Krueger, Elad...> ;Transplantation and Cellular Therapy. 2023 Sep 1
• 6 citations
  CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.
  Jess, J., Yates, B., Dulau-Florea, A., Parker, K., Inglefield, J., Lichtenstein, D., Schischlik, F., Ongkeko, M., Wang, Y., Shahani, S., Cullinane, A., Smith, H., Kane...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 3 citations
  Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells.
  Alexandra Dreyzin, Sandhya R Panch, Haneen Shalabi, Bonnie Yates, Steven L Highfill, Ping Jin, David Stroncek, Nirali N Shah> ;Molecular Therapy. Methods & Clinical Development. 2023 Mar 9
• CD19 CAR T cells for infants and young children.
  Haneen Shalabi, Nirali N Shah> ;The Lancet. Haematology. 2022 Oct 1
• 8 citations
  The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes.
  Aiman J Faruqi, John A Ligon, Paul Borgman, Seth M Steinberg, Toni Foley, Lauren Little, Crystal L Mackall, Daniel W Lee, Terry J Fry, Haneen Shalabi, Jennifer Brudno,...> ;Blood Advances. 2022 Dec 13
• 2 citations
  Chimeric Antigen Receptor T-cell Therapy: Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies.
  Aimee C Talleur, Regina Myers, Colleen Annesley, Haneen Shalabi> ;Hematology/oncology Clinics of North America. 2022 Aug 1
• 14 citations
  Anakinra utilization in refractory pediatric CAR T-cell associated toxicities.
  Caroline Diorio, Anant Vatsayan, Aimee C Talleur, Colleen Annesley, Jennifer J Jaroscak, Haneen Shalabi, Michelle Hudspeth, Shannon L Maude, Rebecca A Gardner, Nirali ...> ;Blood Advances. 2022 Jun 14
• 49 citations
  CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
  Haneen Shalabi, Haiying Qin, Angela Su, Bonnie Yates, Pamela L Wolters, Seth M Steinberg, John A Ligon, Sara Silbert, Kniya DéDé, Mehdi Benzaoui, Sophia Goldberg, Soor...> ;Blood. 2022 Aug 4
• 23 citations
  Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.
  Holland, E., Molina, J., Dede, K., Moyer, D., Zhou, T., Yuan, C., Wang, H., Stetler-Stevenson, M., Mackall, C., Fry, T., Panch, S., Highfill, S., Stroncek, D., Little,...> ;Journal for Immunotherapy of Cancer. 2022 May 1
• 23 citations
  Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.
  Elizabeth M Holland, Bonnie Yates, Alex Ling, Constance M Yuan, Hao-Wei Wang, Maryalice Stetler-Stevenson, Michael LaLoggia, John C Molina, Daniel A Lichtenstein, Dani...> ;Blood Advances. 2022 Apr 12
• 4 citations
  Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies.
  Haneen Shalabi, Staci Martin, Bonnie Yates, Pamela L Wolters, Claire Kaplan, Hannah Smith, Christopher R Sesi, Jennifer Jess, Mary Anne Toledo-Tamula, Kari Struemph, C...> ;Neuro-Oncology. 2022 Sep 1
• 3 citations
  Immunotherapy Associated Neurotoxicity in Pediatric Oncology.
  Haneen Shalabi, Anandani Nellan, Nirali N Shah, Juliane Gust> ;Frontiers in Oncology. 2022 Jan 1
• 6 citations
  Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation.
  John C. Molina, Seth M. Steinberg, Bonnie Yates, Daniel W. Lee, Lauren Little, Crystal L. Mackall, Haneen Shalabi, Nirali N. Shah> ;Transplantation and Cellular Therapy. 2021 Oct 20
• 67 citations
  Characterization of HLH-Like Manifestations as a CRS Variant in Patients Receiving CD22 CAR T-Cells.
  Ombrello, A. K., Daniel A. Lichtenstein, Fiorella Schischlik, Lipei Shao, Seth M. Steinberg, Bonnie Yates, Hao-Wei Wang, Yanyu Wang, Jon Inglefield, Alina Dulau Florea...> ;Blood. 2021 Sep 15
• 8 citations
  Consequences of hemophagocytic lymphohistiocytosis-like cytokine release syndrome toxicities and concurrent bacteremia
  Katherine E. Masih, John A. Ligon, Bonnie Yates, Haneen Shalabi, Lauren Little, Zahin Islam, Jon Inglefield, Veronique Nussenblatt, Maura Manion, Javed Khan, Nirali N....> ;Pediatric Blood & Cancer. 2021 Jul 26
• 142 citations
  Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.
  Nirali N. Shah, Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin, Pamela L. Wolters, Seth M. Steinberg, Eva H. Baker, Cindy Delbrook, Marya...> ;Journal of Clinical Oncology. 2021 Mar 25
• 40 citations
  Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells
  Haneen Shalabi, Juliane Gust, Agne Taraseviciute, Pamela L. Wolters, Allison Barz Leahy, Carlos Sandi, Theodore W. Laetsch, Lori Wiener, Rebecca Gardner, Veronique Nus...> ;Nature Reviews. Clinical Oncology. 2021 Jan 25
• 7 citations
  Case Report: Fatal Complications of BK Virus-Hemorrhagic Cystitis and Severe Cytokine Release Syndrome Following BK Virus-Specific T-Cells.
  Elizabeth M Holland, Corina Gonzalez, Elliot Levy, Vladimir A Valera, Heather Chalfin, Jacquelyn Klicka-Skeels, Bonnie Yates, David E Kleiner, Colleen Hadigan, Hema Da...> ;Frontiers in Immunology. 2021 Jan 1
• 22 citations
  Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia.
  George Mo, Hao-Wei Wang, Aimee C Talleur, Shilpa A Shahani, Bonnie Yates, Haneen Shalabi, Michael G. Douvas, Katherine R. Calvo, Jack F. Shern, Sridhar Chaganti, Katha...> ;Journal for Immunotherapy of Cancer. 2020 Nov 1
• 28 citations
  Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
  Kazusa Ishii, Marie Pouzolles, Christopher D. Chien, Rebecca A. Erwin-Cohen, M. Eric Kohler, Haiying Qin, Haiyan Lei, Skyler Kuhn, Amanda K. Ombrello, Alina Dulau-Flor...> ;The Journal of Clinical Investigation. 2020 Oct 1
• 55 citations
  Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies.
  Haneen Shalabi, Vandana Sachdev, Amita Kulshreshtha, Julia W. Cohen, Bonnie Yates, Doug R Rosing, Stanislav Sidenko, Cindy Delbrook, Crystal L. Mackall, Brandon M. Wil...> ;Journal for Immunotherapy of Cancer. 2020 Sep 1
• 234 citations
  CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
  , , , , , , , , , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2020 Apr 14
• Join now to see all